Nephros (NEPH) Net Income towards Common Stockholders Growth (3y) (2013 - 2026)
Nephros (NEPH) Net Income towards Common Stockholders Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 31.80% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -37.96% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 19.70% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 0.27% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -58.17% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 8.70% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -72.19% |
| 10 | Nephros | 34.19 Mn | 30.17 Mn | 2.99 Mn | 34.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.29% |
| Dec 31, 2025 | 27.39% |
| Sep 30, 2025 | 28.15% |
| Jun 30, 2025 | 30.00% |
| Mar 31, 2025 | 31.72% |
| Dec 31, 2024 | 32.57% |
| Sep 30, 2024 | 29.06% |
| Jun 30, 2024 | 37.54% |
| Mar 31, 2024 | 33.41% |
| Dec 31, 2023 | 7.26% |
| Sep 30, 2023 | 44.63% |
| Jun 30, 2023 | 36.82% |
| Mar 31, 2023 | 35.81% |
| Dec 31, 2022 | -64.83% |
| Sep 30, 2022 | -58.99% |
| Jun 30, 2022 | -6.25% |
| Mar 31, 2022 | -12.97% |
| Dec 31, 2021 | -13.52% |
| Sep 30, 2021 | -31.13% |
| Jun 30, 2021 | -20.37% |